IDS Antikörper (N-Term)
Kurzübersicht für IDS Antikörper (N-Term) (ABIN926632)
Target
Alle IDS Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Aufreinigung
- Purified
-
Immunogen
- IDS antibody was raised in rabbit using the N terminal of IDS as the immunogen
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator.
-
Kommentare
-
IDS Blocking Peptide, (ABIN5614136), is also available for use as a blocking control in assays to test for specificity of this IDS antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- IDS (Iduronate 2-Sulfatase (IDS))
-
Andere Bezeichnung
- IDS
-
Hintergrund
- Iduronate-2-sulfatase is required for the lysosomal degradation of heparan sulfate and dermatan sulfate. Mutations in this X-chromosome gene that result in enzymatic deficiency lead to the sex-linked Mucopolysaccharidosis Type II, also known as Hunter Syndrome. Iduronate-2-sulfatase has a strong sequence similarity with human arylsulfatases A, B, and C, and human glucosamine-6-sulfatase. Multiple alternatively spliced transcript variants that encode different protein isoforms have been described. Synonyms: Polyclonal IDS antibody, Anti-IDS antibody, iduronate 2-sulfatase antibody, MPS2 antibody, SIDS antibody.
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-